Business Description
RetinalGenix Technologies Inc
NAICS : 423450
SIC : 5047
ISIN : US76133Y1055
Total Employee Number:
1Description
RetinalGenix Technologies Inc is an ophthalmic research and development company focused on developing technologies to screen, monitor, diagnose, and treat ocular, optical, and sight-threatening disorders, Its mission is to prevent vision loss and blindness due to diabetic retinopathy and maculopathy through early detection from the use of two devices: Retinal Imaging Screening Device a portable, retinal imaging system providing a wide field of view without requiring pupil dilation; and RetinalCamTM, being designed as a high-resolution home monitoring retinal imaging device and physician alert system offering real-time communication with physicians available.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Equity-to-Asset | -426.33 | |||||
Debt-to-Equity | -0.02 | |||||
Debt-to-EBITDA | -0.02 | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 19.7 | |||||
3-Year EPS without NRI Growth Rate | -2.7 | |||||
3-Year FCF Growth Rate | -32.1 | |||||
3-Year Book Growth Rate | -25.7 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 100 | |||||
9-Day RSI | 100 | |||||
14-Day RSI | 99.99 | |||||
6-1 Month Momentum % | 25 | |||||
12-1 Month Momentum % | 12.99 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -22509.26 | |||||
ROIC % | -4213.54 | |||||
3-Year ROIIC % | -6100 | |||||
ROC (Joel Greenblatt) % | -48540 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -31.08 | |||||
EV-to-EBITDA | -31.1 | |||||
EV-to-FCF | -157.14 | |||||
Earnings Yield (Greenblatt) % | -3.22 | |||||
FCF Yield % | -0.64 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:RTGN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
RetinalGenix Technologies Inc Executives
DetailsGF Value™
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.124 | ||
| Beta | 5329.3458 | ||
| 3-Year Sharpe Ratio | 0.58 | ||
| 3-Year Sortino Ratio | 8745.48 | ||
| Volatility % | 27.68 | ||
| 14-Day RSI | 99.99 | ||
| 14-Day ATR ($) | 0.000297 | ||
| 20-Day SMA ($) | 4 | ||
| 12-1 Month Momentum % | 12.99 | ||
| 52-Week Range ($) | 3.2 - 4.01 | ||
| Shares Outstanding (Mil) | 18.84 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
RetinalGenix Technologies Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
RetinalGenix Technologies Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-13 | In 90 days | ||
| Second quarter earnings results for 2026 | 2026-08-19 | In 4 days | ||
| General meeting for 2025 | 2026-08-17 | In 2 days | ||
| First quarter earnings results for 2026 | 2026-05-20 | 4.00 (+0.00%) | ||
| Annual report for 2025 | 2026-04-15 | 3.20 (+0.00%) | ||
| Third quarter earnings results for 2025 | 2025-11-14 | 3.20 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-08-19 | 3.54 (+0.00%) | ||
| First quarter earnings results for 2025 | 2025-05-15 | 5.02 (+0.00%) | ||
| Annual report for 2024 | 2025-03-31 | 2.01 (+0.00%) | ||
| Third quarter earnings results for 2024 | 2024-11-18 | 3.50 (+0.00%) |
Show
Entries
RetinalGenix Technologies Inc Frequently Asked Questions
What is RetinalGenix Technologies Inc(RTGN)'s stock price today?
The current price of RTGN is $4.00. The 52 week high of RTGN is $4.01 and 52 week low is $3.20.
When is next earnings date of RetinalGenix Technologies Inc(RTGN)?
The next earnings date of RetinalGenix Technologies Inc(RTGN) is 2026-08-19 Est..
Does RetinalGenix Technologies Inc(RTGN) pay dividends? If so, how much?
RetinalGenix Technologies Inc(RTGN) does not pay dividend.
Guru Commentaries on OTCPK:RTGN
No articles.
Press Release
| Subject | Date | ||
|---|---|---|---|
| RetinalGeniX™Technologies, Inc. Announces Listing to OTCQB Venture Market | 2022-03-08 |
Articles on RetinalGenix Technologies Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers